Thymus Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-03-14
Clinical Trial Update: A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies [Phase 2]
Phase 2 study of amrubicin in relapsed or refractory thymic malignancies has completed; results posted.